In CD8+ T cells, tumor reactivity correlates with proliferative programs, as expected for clonally expanding cells, oxidative phosphorylation and glycolysis, processes associated with enhanced CD8+ T cell effector function29 and IFNγ signaling, a key mediator of ICT efficacy11 (Fig. 3d). This evidence concerns the gene CD8A and neoplasm.